Zefei Jiang

11PUBLICATIONS
84CO-AUTHORS
Artificial life and complex adaptive systemsSatisfiability and optimisationCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 13, 2026
Artificial intelligence in breast cancer: applications and advancements.

Jianbin Li, Zefei Jiang

|Apr 13, 2026
Artificial intelligence empowering precision diagnosis and treatment of breast cancer: advancing global clinical practice with regional insights.

Zefei Jiang

|Mar 21, 2026
Dalpiciclib plus chidamide in HR + /HER2-advanced breast cancer after CDK4/6 inhibitor failure: a phase Ib trial.

Jinmei Zhou, Xuexue Wu, Yimeng Du

|Mar 18, 2025
Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis.

Wolfgang Janni, Thomas W P Friedl, Tracy C Yab

|Oct 22, 2024
Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) Guidelines in 2024: International Contributions from China.

Jianbin Li, Zefei Jiang

|May 16, 2024
Primary results of ELAINA: a randomized, multicenter, open-label, phase III study of the efficacy and safety of trastuzumab emtansine <i>vs.</i> lapatinib plus capecitabine in Chinese patients with HER2-positive locally advanced or metastatic breast cancer who have received prior trastuzumab-based therapy.

Xiaojia Wang, Wei Li, Yongmei Yin

Pageof 2

Frequent Collaborators

2 joint publications

Shaohua Zhang

2 joint publications

Jianyun Nie

2 joint publications

Yiding Chen

2 joint publications

Ying Lin